Literature DB >> 25399235

Low energy conformations for gonadotropin-releasing hormone with D- and L-amino acid substitutions for Gly 6: possible receptor-bound conformations.

Matthew R Pincus1, Jannie Woo, Regina Monaco, Jack Lubowsky, Robert P Carty.   

Abstract

In the preceding paper, using ECEPP, including the effects of water, and the chain build-up procedure, we computed the low energy structures for GnRH and found that there were no distinct low energy structures or structures with high statistical weights. To attempt to deduce possible structures of GnRH that may bind to the GnRH receptor, we computed the low energy structures for GnRH peptides that have L- and D-amino acids substituting for Gly 6. The L-amino acid-substituted peptides (L-Ala and L-Val) have very low or no affinity for the receptor and on activity (release of FSH and LH) while the D-Ala-, D-Leu-, D-Trp- and D-Phe-substituted peptides have significantly higher relative affinities and activities than those for native GnRH; the D-Val-substituted peptide has about one-third of the affinity and activity as native GnRH. Unlike native GnRH, our computations suggest that both sets of peptides form well-defined structures in water: the L-amino acid-substituted peptides are predominantly α-helical while the D-amino acid-substituted peptides adopted E*A A A E D*(C*) A E C A(C*) and minor variants of these structures. By eliminating structures that lay in common to the D-Ala and L-Val peptides and further eliminating structures that differed between the D-Ala and D-Leu peptides, we reduced the number of possible distinct binding conformations to 254. Searching for structures among these 254 conformations that had relative statistical weights that paralleled their relative affinities, we found two candidate structures: D*E A A E C*A E C A and D*G A A E D*A E C G*, both of which have conformations for residues 3-9 that are similar to the computed most probable structures for the D-amino acid-substituted GnRH peptides in water.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25399235     DOI: 10.1007/s10930-014-9590-x

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  14 in total

Review 1.  Edward T. Tyler Prize Oration: LH-releasing hormone and its analogues: recent basic and clinical investigations.

Authors:  A V Schally; A J Kastin; D H Coy
Journal:  Int J Fertil       Date:  1976

Review 2.  Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective.

Authors:  M J Karten; J E Rivier
Journal:  Endocr Rev       Date:  1986-02       Impact factor: 19.871

3.  Pituitary receptor binding activity of active, inactive, superactive and inhibitory analogs of gonadotropin-releasing hormone.

Authors:  D Heber; W D Odell
Journal:  Biochem Biophys Res Commun       Date:  1978-05-15       Impact factor: 3.575

4.  Molecular conformation of gonadoliberin using two-dimensional NMR spectroscopy.

Authors:  K V Chary; S Srivastava; R V Hosur; K B Roy; G Govil
Journal:  Eur J Biochem       Date:  1986-07-15

5.  Synthetic analogs of the hypothalamic luteinizing hormone releasing factor with increased agonist or antagonist properties.

Authors:  M W Monahan; M S Amoss; H A Anderson; W Vale
Journal:  Biochemistry       Date:  1973-11-06       Impact factor: 3.162

6.  Analogs of luteinizing hormone-releasing hormone with increased biological activity produced by D-amino acid substitutions in position 6.

Authors:  D H Coy; J A Vilchez-Martinez; E J Coy; A V Schally
Journal:  J Med Chem       Date:  1976-03       Impact factor: 7.446

7.  On the biologically active structures of cholecystokinin, little gastrin, and enkephalin in the gastrointestinal system.

Authors:  M R Pincus; R P Carty; J Chen; J Lubowsky; M Avitable; D Shah; H A Scheraga; R B Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Enzymatic stability, solution structure, and antiproliferative effect on prostate cancer cells of leuprolide and new gonadotropin-releasing hormone peptide analogs.

Authors:  Eleni V Pappa; Aikaterini A Zompra; Zinovia Spyranti; Zoi Diamantopoulou; George Pairas; Fotini N Lamari; Panagiotis Katsoris; Georgios A Spyroulias; Paul Cordopatis
Journal:  Biopolymers       Date:  2011       Impact factor: 2.505

9.  Structure-activity studies of lGnRH-III through rational amino acid substitution and NMR conformational studies.

Authors:  Eleni V Pappa; Aikaterini A Zompra; Zoi Diamantopoulou; Zinovia Spyranti; George Pairas; Fotini N Lamari; Panagiotis Katsoris; George A Spyroulias; Paul Cordopatis
Journal:  Biopolymers       Date:  2012       Impact factor: 2.505

10.  Binding affinity and biological activity of gonadotropin releasing hormone agonists in isolated pituitary cells.

Authors:  E Loumaye; Z Naor; K J Catt
Journal:  Endocrinology       Date:  1982-09       Impact factor: 4.736

View more
  2 in total

1.  Low Energy Conformations for S100 Binding Peptide from the Negative Regulatory Domain of p53.

Authors:  Robert P Carty; Bo Lin; Daniel Fridman; Matthew R Pincus
Journal:  Protein J       Date:  2018-12       Impact factor: 2.371

Review 2.  The Structural Basis of Peptide Binding at Class A G Protein-Coupled Receptors.

Authors:  Oanh Vu; Brian Joseph Bender; Lisa Pankewitz; Daniel Huster; Annette G Beck-Sickinger; Jens Meiler
Journal:  Molecules       Date:  2021-12-30       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.